A Self-Cross-Linked Dual-Enzyme Assembly for Safe and Efficient Hyperuricemia Therapy
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c01468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Jong-Ha Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Pukyong National University, Yongso-ro 45, Nam-gu, Busan 48513, South Korea. Hauptthemen laut MEDLINE: Hyperuricemia, Urate Oxidase, Catalase. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Institute of Marine Science and Technology promotion.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Pukyong National University, Yongso-ro 45, Nam-gu, Busan 48513, South Korea.
ORCID-Profile: Jong-Ha Park, Sung In Lim
Förderung
- National Research Foundation of Korea
- Korea Institute of Marine Science and Technology promotion
Zitieren
APA
Park, J. H., Cho, Y. J., & Lim, S. I. (2026). A Self-Cross-Linked Dual-Enzyme Assembly for Safe and Efficient Hyperuricemia Therapy. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01468
Vancouver
Park JH, Cho YJ, Lim SI. A Self-Cross-Linked Dual-Enzyme Assembly for Safe and Efficient Hyperuricemia Therapy. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c01468
BibTeX
@article{Park2026,
author = {Park, Jong-Ha and Cho, Yong Joon and Lim, Sung In},
title = {A Self-Cross-Linked Dual-Enzyme Assembly for Safe and Efficient Hyperuricemia Therapy},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c01468}
}
EUVIMED